Canada markets close in 1 hour 19 minutes

IVERIC bio, Inc. (ISEE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.10+0.21 (+1.01%)
As of 02:41PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close20.89
Open21.05
Bid21.20 x 1300
Ask21.21 x 1200
Day's Range20.67 - 21.48
52 Week Range8.85 - 24.33
Volume804,414
Avg. Volume3,948,765
Market Cap2.829B
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Motley Fool

    IVERIC bio, Inc. (ISEE) Q3 2022 Earnings Call Transcript

    Representing IVERIC Bio today are Glenn Sblendorio, chief executive officer; Dr. Pravin Dugel, president; Keith Westby, chief operating officer; David Carroll, chief financial officer; Dr. Dhaval Desai, chief development officer; Chris Simms, chief commercial officer; and Tony Gibney, chief business and strategy officer. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date.

  • Motley Fool

    Why Iveric Bio Stock Is Skyrocketing This Week

    Investors are applauding the company's late-stage clinical results for its lead pipeline candidate.

  • Zacks

    IVERIC bio (ISEE) Posts Positive Top-Line Data From GA Study

    IVERIC bio (ISEE) reports positive top-line data from the phase III GATHER2 study, evaluating its investigational candidate, Zimura, for the treatment of geographic atrophy. Stock up.